Intro To Pathology Flashcards

1
Q

What does pathology include?

A
Aetiology,
Epidemiology (incidence),
Presentation (signs and symptoms),
Morphology of the disease (gross and macroscopic features),
Molecular features,
Complications,
Prognosis/outcome,
Management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What factors might influence the response of cells the mimic a disease state?

A
Trauma,
Radiation damage,
Environmental factors,
Infectious agents,
Carcinogenic substances,
Others; congenital, degenerative, vascular.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How may cells respond to damaging stimuli?

A

1) . Adaptation - usually physiological, reversible. Includes hyperplasia, hypertrophy, atrophy, metaplasia.
2) . Cell death - severe injury (apoptosis and necrosis).
3) . Genetic derangement - usually irreversible. Benign or malignant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe hyperplasia.

A

Hyperplasia is when proliferation of cells exceeds a normal level.

Hyperplasia may result in the gross enlargement of an organ or tissue.

And example is epidermal hyperplasia secondary to friction and endometrial hyperplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe hypertrophy.

A

Hypertrophy is the increase in the volume of an organ or tissue due to the enlargement of its component cells but not the number of component cells.

It may be pure hypertrophy (i.e. heart muscle in hypertension) or more frequently associated with hyperplasia (increase in both number and size of the cells, e.g. Uterus in pregnancy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe atrophy.

A

Atrophy is the partial or complete wasting of an organ or part of the body.

Atrophy may be caused by genetic mutations, poor nourishment, poor circulation, loss of hormonal support, loss of nerve supply to the target organ, disuse or lack or exercise.

Examples include atrophy of the thymus after puberty and limb/muscle atrophy in paralysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is an example of hyperplasia?

A

Epidermal hyperplasia secondary to friction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Give an example of pure hypertrophy.

A

Hypertrophy of the heart muscle in hypertension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Give an example of a situation where hypertrophy and hyperplasia occur simultaneously.

A

In the uterus during pregnancy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give an example of a situation where atrophy occurs.

A

Muscle atrophy due to lack of exercise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is metaplasia?

A

Metaplasia is a reversible change in which one adult cell type is replaced by another adult cell type.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Give an example of squamous metaplasia.

A

Suqamous metaplasia occurs in the upper respiratory tract in smokers. The columnar or transitional epithelium is replaced by squamous epithelium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give an example of a situation where columnar metaplasia occurs.

A

In Barrett’s oesophagus the squamous epithelium changes to columnar epithelium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is dysplasia?

A

It is an alteration to adult cells that is characterised by variation in their size, shape and organisation.

Dysplasia can be used to refer to developmental abnormalities such as renal dysplasia, or more commonly neoplastic abnormalities such as epidermal dysplasia.

In neoplastic dysplasia the changes are reversible in the early stages but at later stages (carcinoma in situ) there may be further deviation from the norm leading to invasive cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is neoplasia?

A

Neoplasia is excessive, unregulated, autonomous growth, usually irreversible proliferation resulting from genetic alteration.

Neoplastic lesions are either benign or malignant (in situ or invasive).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the two components that all tumour consist of?

A

1) . Parenchyma - proliferating neoplastic cells.

2) . Supportive Stroma - blood vessels and connective tissue.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is tumour nomenclature based on?

A

Tumour nomenclature is based on parenchymal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What effect does the stromal support have on the consistency of a tumour?

A

If stromal support is scanty then the neoplam will be soft and fleshy.

If stromal support is abundant and forms collagen and scar-like tissue then the tumour will be hard (e.g. Schirrous carcinoma of the breast).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What influences whether a tumour is benign or malignant?

A

The neoplastic changes in the target cells. It depends how these changes influence the cells ability to grow and or invade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What distinguishes a malignant tumour from a benign tumour?

A

Neoplastic transformation is a malignant and aggressive process rather than the benign and limited process that takes place in benign tumours.

Malignant tumours will display local invasion of the basement membrane, stroma and blood vessels and distant metastasis may form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What suffix is added on to the cell of origin when describing benign tumours?

A

The suffix -oma.

e.g. Fibroma, lipoma, chondroma, haemagioma, adenoma, papilloma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is a carcinoma?

A

A malignant tumour arising from epithelial tissue. May be in situ with an in tact basement membrane or invasive (primary or metastatic).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is a sarcoma?

A

A sarcoma is a malignant tumour arising from mesenchymal tissue. All sarcomas will be invasive as there is no basement membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How are carcinomas sub-classified?

A

Carcinomas are sub-classified based on origin or pattern.

E.g. Squamous carcinoma, adenocarcinoma.

Pattern may be signet cell, mucinous, angiomatous, lympho-epithelioma.

Often the organ of origin is also added (e.g. Renal cell adenocarcinoma, bronchogenic carcinoma).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How are sarcomas sub-classified?

A

They have different names depending on the cells of origin (e.g. Fibrosarcoma, liposarcoma).

26
Q

What is the diagnosis of tumours based on?

A
Symptoms,
Signs from physical examination,
Imaging,
Tumour markers,
Biopsy
27
Q

What are tumour markers? What are they used for?

A

Certain tumours liberate products that can be detected on the blood, urine, CSF samples, thereby acting as tumour markers.

These may aid diagnosis but may also be used to follow up therapy when blood levels become increased, often before imaging can detect recurrence.

28
Q

List some methods for collecting tissue samples.

A

FNA, fluid cytology, needle core biopsy, endoscopic biopsy, punch biopsy, surgical biopsy, excision, exfoliative cytology.

29
Q

What are p the advantages of using tri-cut/needle core biopsies as opposed to FNA?

A

Tri-cut/needle core biopsies allow for not only cells, but the tissue in context to be taken.

It gives bigger biopsies than FNA. Pathologists may be able to comment on tumour architecture, type and grade.

30
Q

What is an excisional biopsy?

A

The whole tumour is taken, generally limited to small tumours, complete excision of lump or lymphnodes, definitive diagnostic procedure.

31
Q

What are surgical biopsies used for?

A

Surgical biopsies include incisional biopsies where just a sample is taken. They are mainly used for diagnostic rather than therapeutic purposes.

32
Q

What can the pathologist tell you about a tumour?

A

The nature of the tumour (benign, malignant, in situ, invasive, hitologic type),
Spread to lymph nodes,
Tumour grade (degree if differentiation),
Involvement of lymphatic blood vessels,
Excision margins and completeness of excision,
Molecular markers (diagnostic, prognostic and predictive).

33
Q

Give a tumour type with excellent prognosis.

A

Thyroid.

34
Q

Give some tumour types that have a moderate prognosis for crude survival.

A

Kidney, prostate, cervix, breast.

35
Q

Give examples of tumours that generally have poor prognosis.

A

Pancreas, brain, oesophagus.

36
Q

Explain what is meant by the grade of a tumour?

A

The grade of the tumour refers to the differentiation of tumour cells relative to the normal tissue of origin (pattern).

It is dependent on variation in the size and shape of constituent cells of the tumour (pleomorphism).

These are very general rules and have to be considered with all other clinical aspects.

The proportion of cells containing mitotic figures (proliferative index) can give you the speed of growth. Low grade tumours are slow growing and have a good prognosis. High grade tumours are fast growing and have a poor prognosis.

37
Q

What does the tumour stage describe?

A

The tumour stage indicates the size of a primary tumour, the degree to which it has locally invaded and the extent to which it has spread by distant metastasis.

38
Q

Describe the international TNM tumour grading system.

A

The TNM system is based upon the extent of local tumour spread, regional lymph node involvement and the presence of distant metastases.

Tumour Nodes Metastases.

It can be applied to many different types of tumour, although the specific criteria are different for each tumour site. There are different T, M and Z cut offs for different tumour sites. Spread to distant nodes will give a higher N score.

T = tumour score = size and whether the tumour has spread locally.
N = Nodes = how many and what levels are involved.
M = Metastases = number of organs involved and the number of metastatic deposits
39
Q

What are the routes of metastasis?

A

Lymphatic,
Haematogenous,
Seeding of body, cavities and surfaces

40
Q

Give an example of a tumour staging system other than the TNM grading system.

A

Dukes staging.

41
Q

Describe Dukes staging system.

A

Dukes staging system is still used in colorectal cancer.

Stage A) - Tumour does not extend beyond muscularis propria. No nodal involvement.

Stage B) - Tumour DOES extend beyond muscularis propria. No nodal involvement.

Stage C) - Any depth of tumour. Tumour present in nodes.

42
Q

What implication does the stage of the tumour have on prognosis?

A

The stage of a tumour is generally the most important indicator of likely prognosis and of appropriate therapy.

Advance stage tumours (extensive spread) may require aggressive treatment.

Early stage tumours (localised) may be treatable by relatively conservative measures.

Special stains can be used to help staging and classifying tumours in terms of their grading and characteristics.

43
Q

What special stains can be used to help staging and classifying tumours in terms of their grading and characteristics?

A

Mucin markers: D-PAS, Alcian blue to detect adenocarcinomas.

Glycogen: PAS (clear cell carcinoma)

Lipid: Sudan III (liposarcoma)

Basement membrane markers (D-PAS)

Neuroendocrine markers (silver)

44
Q

What stains can be used to detect mucins? What tumours might these stains be used to detect?

A

D-PAS, Alcian blue.

May be used to detect adenocarcinomas.

45
Q

What stain can be used to detect glycogen? What tumours might this be used to identify?

A

PAS.

Clear cell carcinoma.

46
Q

What stain can be used to detect lipids? What tumours might this be used to detect?

A

Sudan III.

Liposarcoma.

47
Q

What stain could you used to detect the basement membrane?

A

D-PAS.

48
Q

What kind of stains might you use to detect neuroendocrine markers?

A

Silver based stains.

49
Q

What is the basic principle of ICC?

A

Monoclonal and polyclonal antibodies can be used to diagnose and classify tumours such as lymphomas and describe their immune phenotype.

50
Q

What ICC markers may be used to identify lymphoma?

A

CD20, CD3, CD15, CD30.

51
Q

What ICC marker may be used to identify ovarian cancer?

A

CA125.

52
Q

What ICC marker may be used to identify pancreatic cancer?

A

CA 19.9

53
Q

What ICC marker might be used to identify colorectal cancer?

A

CEA.

54
Q

What ICC markers may be used to identify prostatic adenocarcinomas?

A

PSA and PSAP.

55
Q

What are the 3 main types of tumour therapy?

A

1) . Surgery
2) . Radiotherapy
3) . Chemotherapy

Multimodal therapy is common. Pathology is pivotal in deciding on appropriate therapy.

56
Q

What will be discussed in an MDTM regarding the possibility of treatment for a patient with a tumour?

A

What is the tumour?
What is the stage and grade of the tumour?
Are there any other clinical factors?
Is therapy possible? (Medically possible, affordable, in patient’s best interests).

57
Q

What does tumour prognosis depend upon?

A

Tumour type, stage and grade.

58
Q

What does pathological examination usually involve?

A

Pathological diagnosis involves sampling, examination using routine stains, special stains, IHC and molecular pathology (may add important information) and then determination of diagnosis and assessment of prognostic and predictive factors for management.

59
Q

Diagnosis of malignancy are usually based on what 3 contributing diagnostic factors?

A

Clinical diagnosis,
Radiological diagnosis,
Pathological diagnosis.

60
Q

What is pathology?

A

The study of disease.